BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8832772)

  • 1. Effects of ORG-2766 on brain event-related potentials of autistic children.
    Verbaten MN; Kemner C; Buitelaar JK; van Ree JM; van Beijsterveld CE; van Engeland H
    Psychiatry Res; 1996 Jun; 63(1):33-45. PubMed ID: 8832772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory event-related brain potentials in autistic children and three different control groups.
    Kemner C; Verbaten MN; Cuperus JM; Camfferman G; van Engeland H
    Biol Psychiatry; 1995 Aug; 38(3):150-65. PubMed ID: 7578658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.
    Smolnik R; Perras B; Molle M; Fehm HL; Born J
    J Clin Psychopharmacol; 2000 Aug; 20(4):445-54. PubMed ID: 10917406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Event-related potentials and monoamines in autistic children on a clinical trial of fenfluramine.
    Oades RD; Stern LM; Walker MK; Clark CR; Kapoor V
    Int J Psychophysiol; 1990 Apr; 8(3):197-212. PubMed ID: 2187009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine effects on ERPs and performance in an auditory Go/NoGo task.
    Barry RJ; Johnstone SJ; Clarke AR; Rushby JA; Brown CR; McKenzie DN
    Clin Neurophysiol; 2007 Dec; 118(12):2692-9. PubMed ID: 17905651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal visual event-related potentials of autistic children.
    Verbaten MN; Roelofs JW; van Engeland H; Kenemans JK; Slangen JL
    J Autism Dev Disord; 1991 Dec; 21(4):449-70. PubMed ID: 1778960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Event-related potentials in autistic and healthy children on an auditory choice reaction time task.
    Oades RD; Walker MK; Geffen LB; Stern LM
    Int J Psychophysiol; 1988 Mar; 6(1):25-37. PubMed ID: 3372271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cocaine on P3B in cocaine abusers.
    Herning RI; Glover BJ; Guo X
    Neuropsychobiology; 1994; 30(2-3):132-42. PubMed ID: 7800160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERPs in schizophrenia: effects of antipsychotic medication.
    Ford JM; White PM; Csernansky JG; Faustman WO; Roth WT; Pfefferbaum A
    Biol Psychiatry; 1994 Aug; 36(3):153-70. PubMed ID: 7948453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual and somatosensory event-related brain potentials in autistic children and three different control groups.
    Kemner C; Verbaten MN; Cuperus JM; Camfferman G; Van Engeland H
    Electroencephalogr Clin Neurophysiol; 1994 May; 92(3):225-37. PubMed ID: 7514992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Event-related potentials, spatial orienting, and reading disabilities.
    Harter MR; Anllo-Vento L; Wood FB
    Psychophysiology; 1989 Jul; 26(4):404-21. PubMed ID: 2798690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Event-related potential study of novelty processing abnormalities in autism.
    Sokhadze E; Baruth J; Tasman A; Sears L; Mathai G; El-Baz A; Casanova MF
    Appl Psychophysiol Biofeedback; 2009 Mar; 34(1):37-51. PubMed ID: 19199028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.
    Smolnik R; Mölle M; Fehm HL; Born J
    Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.
    Pietrowsky R; Strüben C; Mölle M; Fehm HL; Born J
    Biol Psychiatry; 1996 Mar; 39(5):332-40. PubMed ID: 8704064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children.
    Buitelaar JK; van Engeland H; van Ree JM; de Wied D
    J Autism Dev Disord; 1990 Dec; 20(4):467-78. PubMed ID: 2177746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of stimulus deviance and novelty on the P300 and novelty P3.
    Goldstein A; Spencer KM; Donchin E
    Psychophysiology; 2002 Nov; 39(6):781-90. PubMed ID: 12462506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.
    Franken IH; Nijs I; Pepplinkhuizen L
    Psychopharmacology (Berl); 2008 Jan; 195(4):537-46. PubMed ID: 17891382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methylphenidate on event-related potentials and performance of attention-deficit hyperactivity disorder children in auditory and visual selective attention tasks.
    Jonkman LM; Kemner C; Verbaten MN; Koelega HS; Camfferman G; vd Gaag RJ; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1997 Mar; 41(6):690-702. PubMed ID: 9066993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
    Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
    Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior.
    Buitelaar JK; van Engeland H; de Kogel KH; de Vries H; van Hooff JA; van Ree JM
    Biol Psychiatry; 1992 Jun; 31(11):1119-29. PubMed ID: 1326339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.